
RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis
Keywords: AUC; AUC; area under curve; Dpi; day post immunization; EAE; experimental autoimmune encephalomyelitis; MOG; myelin oligodendrocyte glycoprotein; MS; multiple sclerosis; POL1; RNA Polymerase-1; POL2; RNA Polymerase-2; RR; relapsing-remitting; SPCs; Splenocytes